← Back to Search

Virus Therapy

IMM-BCP-01 for COVID-19

Phase 1
Recruiting
Research Sponsored by Immunome, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights

Summary

This trial is testing a new drug, IMM-BCP-01, to see if it is safe and effective in treating people with mild to moderate COVID-19. The study will last 28 days, and will measure safety, tolerability, and viral clearance.

Eligible Conditions
  • COVID-19
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Anti drug antibody
Incidence and severity of Treatment Emergent Adverse Events (TEAEs)
PK parameters
+1 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: IV Cohort 4 (optional)Experimental Treatment2 Interventions
Single intravenous (IV) dose 4 of IMM-BCP-01 or matching placebo
Group II: IV Cohort 3Experimental Treatment2 Interventions
Single intravenous (IV) dose 1 of IMM-BCP-01 or matching placebo
Group III: IV Cohort 2Experimental Treatment2 Interventions
Single intravenous (IV) dose 2 of IMM-BCP-01 or matching placebo
Group IV: IV Cohort 1Experimental Treatment2 Interventions
Single intravenous (IV) dose 1 of IMM-BCP-01 or matching placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
875 Previous Clinical Trials
329,950 Total Patients Enrolled
19 Trials studying COVID-19
6,939 Patients Enrolled for COVID-19
Immunome, Inc.Lead Sponsor
~12 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top